Jacobio (01167) Announces Monthly Return for February 2026

Bulletin Express
Yesterday

Jacobio Pharmaceuticals Group Co., Ltd. (stock code: 01167) disclosed its monthly return report for the period ended 28 February 2026. The total authorized share capital remained at USD 100,000, representing 1.00 billion ordinary shares with a par value of USD 0.0001 each.

At the end of the month, the total number of issued shares (excluding treasury shares) stood at 786.67 million, with 5.08 million treasury shares held, resulting in 791.76 million shares issued in total. According to the filing, the company confirmed that it has satisfied the applicable public float requirement, specified at 25%. No changes were recorded in share options, warrants, convertibles, or other share issuance arrangements during this period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10